Adventist Health Clearlake - Medicare Critical Access Hospital in Clearlake, CA

Name	Adventist Health Clearlake
Type	Critical Access Hospital
Location	15630 18th Ave - Hwy 53, Clearlake, California
Ownership	Voluntary non-profit - Private
Emergency Services	Yes
Medicare ID (CCN)	051317

Yes Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital

Always Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean

Always Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night

Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well

Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well

Always Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted

Always Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them

Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home

Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital

Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Adventist Health Clearlake from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1104080944
Organization Name	ADVENTIST HEALTH CLEARLAKE HOSPITAL, INC
Doing Business As	ADVENTIST HEALTH CLEAR LAKE
Address	18th Ave And Highway 53, Clearlake, CA 95422
Hospital Type	General Acute Care Hospital - Rural
Phone Number	707-994-6486

News Archive

Stentys' self-expanding and drug-eluting stents demonstrate promising results in 'OPEN-I' clinical study

Medical device pioneer Stentys announced today that the complete ‘OPEN-I' clinical study was presented by Stefan Verheye, M.D., Ph.D., at the Joint Interventional Meeting ("JIM") 2010 in Rome, demonstrating superior results in 60 patients (27 Stentys drug-eluting stents and 33 Stentys bare-metal stents) who were followed–up angiographically after six months.

Advanced Biomaterial Systems receives U.S. patent for mixing and dispensing apparatus

Advanced Biomaterial Systems, Inc. (ABS) has received U.S. patent 6,984,063 for an Apparatus for Mixing and Dispensing Components. This patent is a continuation of several patents which incorporate twistOR and Plexis technology.

Researcher aims to make early detection of melanoma faster, cheaper without need for biopsy

Melanoma is a form of skin cancer that becomes dangerous when it spreads, but is treatable in its early stages. Doctors diagnose melanoma by cutting away a piece of a suspicious skin lesion - a procedure known as a biopsy - and testing it for malignant cells.

Phase III GOG-212 clinical trial of CTI's OPAXIO for ovarian cancer: Enrollment to continue

Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.

Read more Medical News

› Verified 6 days ago

NPI Number	1124018031
Organization Name	ADVENTIST HEALTH CLEARLAKE HOSPITAL INC.
Doing Business As	ADVENTIST HEALTH CLEAR LAKE
Address	15630 18th Ave, Clearlake, CA 95422
Hospital Type	General Acute Care Hospital - Critical Access
Phone Number	707-994-6486

News Archive

Stentys' self-expanding and drug-eluting stents demonstrate promising results in 'OPEN-I' clinical study

Medical device pioneer Stentys announced today that the complete ‘OPEN-I' clinical study was presented by Stefan Verheye, M.D., Ph.D., at the Joint Interventional Meeting ("JIM") 2010 in Rome, demonstrating superior results in 60 patients (27 Stentys drug-eluting stents and 33 Stentys bare-metal stents) who were followed–up angiographically after six months.

Advanced Biomaterial Systems receives U.S. patent for mixing and dispensing apparatus

Advanced Biomaterial Systems, Inc. (ABS) has received U.S. patent 6,984,063 for an Apparatus for Mixing and Dispensing Components. This patent is a continuation of several patents which incorporate twistOR and Plexis technology.

Researcher aims to make early detection of melanoma faster, cheaper without need for biopsy

Melanoma is a form of skin cancer that becomes dangerous when it spreads, but is treatable in its early stages. Doctors diagnose melanoma by cutting away a piece of a suspicious skin lesion - a procedure known as a biopsy - and testing it for malignant cells.

Phase III GOG-212 clinical trial of CTI's OPAXIO for ovarian cancer: Enrollment to continue

Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.

Read more Medical News

› Verified 6 days ago

NPI Number	1487897047
Organization Name	ADVENTIST HEALTH CLEARLAKE HOSPITAL INC.
Doing Business As	ST HELENA HOSPITAL-CLEARLAKE
Address	15630 18th Ave, Clearlake, CA 95422
Hospital Type	General Acute Care Hospital - Critical Access
Phone Number	707-994-6486

News Archive

Stentys' self-expanding and drug-eluting stents demonstrate promising results in 'OPEN-I' clinical study

Medical device pioneer Stentys announced today that the complete ‘OPEN-I' clinical study was presented by Stefan Verheye, M.D., Ph.D., at the Joint Interventional Meeting ("JIM") 2010 in Rome, demonstrating superior results in 60 patients (27 Stentys drug-eluting stents and 33 Stentys bare-metal stents) who were followed–up angiographically after six months.

Advanced Biomaterial Systems receives U.S. patent for mixing and dispensing apparatus

Advanced Biomaterial Systems, Inc. (ABS) has received U.S. patent 6,984,063 for an Apparatus for Mixing and Dispensing Components. This patent is a continuation of several patents which incorporate twistOR and Plexis technology.

Researcher aims to make early detection of melanoma faster, cheaper without need for biopsy

Melanoma is a form of skin cancer that becomes dangerous when it spreads, but is treatable in its early stages. Doctors diagnose melanoma by cutting away a piece of a suspicious skin lesion - a procedure known as a biopsy - and testing it for malignant cells.

Phase III GOG-212 clinical trial of CTI's OPAXIO for ovarian cancer: Enrollment to continue

Cell Therapeutics, Inc. announced today that CTI received a statement on March 1, 2010 from the Gynecologic Oncology Group (GOG) leadership that the phase III GOG-212 clinical trial of CTI's OPAXIO™ used as maintenance therapy for ovarian cancer remains a high priority and enrollment will continue. The GOG made the statement to clarify that the recent results of the GOG-218 clinical trial bevacizumab in maintenance therapy for ovarian cancer has not influenced the importance of completing the GOG-212 clinical trial.

Read more Medical News

› Verified 6 days ago

Able to receive lab results electronically	Not Available
Able to track patients' lab results, tests, and referrals electronically between visits	Not Available

Hospitals in Clearlake, CA

Adventist Health Clearlake Critical Access Hospital Location: 15630 18th Ave - Hwy 53, Clearlake, California 95422 Phone: (707) 994-6486

Medicare Hospital Compare

Hospital Compare provide information about the quality of care at over 4,000 Medicare-certified hospitals across the country. You can use Hospital Compare to find hospitals and compare the quality of their care. The information on Hospital Compare:

• Helps you make decisions about where you get your health care
• Encourages hospitals to improve the quality of care they provide

In an emergency, you should go to the nearest hospital. When you can plan ahead, discuss the information you find here with your health care provider to decide which hospital will best meet your health care needs. Hospital Compare was created through the efforts of the Centers for Medicare & Medicaid Services (CMS), in collaboration with organizations representing consumers, hospitals, doctors, employers, accrediting organizations, and other federal agencies.